Sharda Cropchem Ltd
NSE:SHARDACROP
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
321.15
816.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sharda Cropchem Ltd
Sharda Cropchem Ltd
Total Liabilities & Equity
Sharda Cropchem Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sharda Cropchem Ltd
NSE:SHARDACROP
|
Total Liabilities & Equity
₹38.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
UPL Ltd
NSE:UPL
|
Total Liabilities & Equity
₹875.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Total Liabilities & Equity
₹54.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Total Liabilities & Equity
₹46B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Total Liabilities & Equity
₹107.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Total Liabilities & Equity
₹169.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Sharda Cropchem Ltd
Glance View
Sharda Cropchem Ltd. is a holding company, which engages in the marketing and distribution of formulations and generic active ingredients. The company is headquartered in Mumbai, Maharashtra and currently employs 175 full-time employees. The company went IPO on 2014-09-23. The firm is principally engaged in export of agro chemicals and non-agro products to various countries across the world. The firm operates through two segments: Agrochemicals and Non Agrochemicals. Its Agrochemicals segment is engaged in the marketing and distribution of formulations and generic active ingredients across insecticides, herbicides, fungicides and biocides for protecting various kinds of crops as well as serves turf and specialty markets. Its Non Agrochemicals segment is engaged in the order-based procurement and supply of conveyor belts, V belts and timing belts, dyes and dye intermediates, and general chemical. The company supplies its non-agro products to over 30 countries across Europe, North America, Latin America, Australia, and Asia. Its subsidiaries include Axis Crop Science Private Limited, Sharda Peru SAC, Sharda Del Ecuador CIA. Ltda., Sharda Polska SP. Z.O.O., Sharda Ukraine LLC and others.
See Also
What is Sharda Cropchem Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
38.3B
INR
Based on the financial report for Sep 30, 2024, Sharda Cropchem Ltd's Total Liabilities & Equity amounts to 38.3B INR.
What is Sharda Cropchem Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
15%
Over the last year, the Total Liabilities & Equity growth was 15%. The average annual Total Liabilities & Equity growth rates for Sharda Cropchem Ltd have been 12% over the past three years , 16% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
